Advertisement

U.S. Markets closed

S&P Futures
5,778.75
+16.75(+0.29%)
Dow Futures
42,505.00
+62.00(+0.15%)
Nasdaq Futures
20,139.50
+111.25(+0.56%)
Russell 2000 Futures
2,263.00
+10.40(+0.46%)
Crude Oil
71.40
+0.40(+0.56%)
Gold
2,644.40
-1.80(-0.07%)

Horizon Therapeutics Public Lim (HZNP)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

116.30

0.00

(0.00%)

At close: 04:00PM EDT

Trade prices are not sourced from all markets

All

Business Wire
Rule 17(e) Announcement - Horizon Therapeutics plc
DUBLIN, October 06, 2023-- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Business Wire
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
DUBLIN, October 03, 2023--IRISH TAKEOVER PANEL
Business Wire
Horizon Therapeutics plc Announces New UPLIZNA? (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
DUBLIN, October 02, 2023--Horizon Therapeutics plc announces new UPLIZNA data in neuromyelitis optica spectrum disorder (NMOSD) to be presented at ECTRIMS 2023.